Compounds > aldosterone
Page last updated: 2024-08-17

aldosterone and fenofibrate

aldosterone has been researched along with fenofibrate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, L; De Silva, DS; Duhaney, TA; Lebrasseur, NK; Liao, R; Ngoy, S; Rude, MK; Sam, F; Siwik, DA1
Cui, L; De Silva, DS; Duhaney, TA; Ip, PC; Joseph, L; Lebrasseur, NK; Sam, F1
Bak, S; Coleman, T; Osher, E; Semenkovich, CF; Stern, N; Tordjman, KM; Vechoropoulos, M; Yudovich, R1
De Silva, DS; Garcia, AG; Hutchinson, C; Ip, PC; Ito, M; Lancel, S; Pimentel, DR; Sam, F; Wilson, RM1
Bu, S; Dai, M; Gonzalez, FJ; Liu, A; Luo, M; Song, D; Wang, W; Zhang, B1

Other Studies

5 other study(ies) available for aldosterone and fenofibrate

ArticleYear
Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:5

    Topics: Aldosterone; Animals; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Fenofibrate; Fibrosis; Hypertension; Hypolipidemic Agents; Kaplan-Meier Estimate; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred Strains; Myocardium; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptors; Phosphorylation; PPAR alpha; Time Factors; Tissue Inhibitor of Metalloproteinases; Ventricular Function, Left

2007
Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:3

    Topics: Aldosterone; Animals; Blood Pressure; Extracellular Matrix; Fenofibrate; Fibrosis; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Lipid Metabolism; Matrix Metalloproteinase 2; Mice; Mice, Inbred Strains; Myocardium; Peroxisome Proliferator-Activated Receptors; Systole; Tissue Inhibitor of Metalloproteinase-2; Ventricular Remodeling

2007
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5

    Topics: Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiomegaly; Diet, Atherogenic; Disease Models, Animal; Fenofibrate; Genotype; Humans; Hypertension; Hypolipidemic Agents; Mice; Mice, Knockout; Mice, Transgenic; PPAR alpha; Renin; Renin-Angiotensin System

2007
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:6

    Topics: Aldosterone; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Cells, Cultured; Drug Interactions; Eplerenone; Fenofibrate; Hypolipidemic Agents; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred Strains; Mineralocorticoid Receptor Antagonists; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; PPAR alpha; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Spironolactone

2009
PPARĪ±-dependent increase of mouse urine output by gemfibrozil and fenofibrate.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:2

    Topics: Alanine Transaminase; Aldosterone; Animals; Arginine Vasopressin; Aspartate Aminotransferases; Blood Urea Nitrogen; Creatinine; Diuretics; Fenofibrate; Gemfibrozil; Hepatomegaly; Homeostasis; Kidney; Liver; Male; Mice; Mice, Knockout; PPAR alpha

2017